RFA is effective and safe in treating unifocal PTMCs with BRAF V600E mutation, especially when surgery is not feasible or refused by patients who are unwilling to continue active surveillance.
Keyphrases
- papillary thyroid
- radiofrequency ablation
- lymph node metastasis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- minimally invasive
- newly diagnosed
- peritoneal dialysis
- coronary artery bypass
- squamous cell carcinoma
- prognostic factors
- metastatic colorectal cancer
- atrial fibrillation
- coronary artery disease